Skip to content
July 11, 2024

Blood Culture Bottle Shortage

The U.S. Food and Drug Administration (FDA) has issued an alert to healthcare providers and laboratories of a shortage of Becton Dickinson (BD) blood test tubes used to diagnose bacterial and fungal infections. BD sent a letter to system users on June 11 informing of possible delays in supply of blood culture media over the coming months due to reduced availability of plastic bottles from a supplier.

According to the FDA, the disruption in supply of this device is expected to impact patient diagnosis, follow up patient management, and antimicrobial stewardship efforts. The FDA recommends laboratories and healthcare providers consider conservation strategies to prioritize the use of blood culture media bottles, preserving the supply for patients at highest risk.

The shortage is expected over the next several months and BD has said it will provide an update on supply by September. “While this supplier issue is not expected to have a material financial impact on BD, we are fully focused on returning the supply of blood culture vials to normal levels,” Nikos Pavlidis, president of BD Diagnostic Solutions, said in a statement.

In developing strategies to preserve the supply for patients at highest risk, please consider the following: